The St. Jude Children's Research Hospital—Washington University Pediatric Cancer Genome Project reports that a highly aggressive form of leukemia in infants has surprisingly few mutations beyond the chromosomal rearrangement ...
Mar 6, 2015
0
108
Cancer stem cells are like zombies—even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors. Researchers ...
Jun 9, 2016
0
125
Social determinants of health affect the outcomes of many illnesses, and pediatric cancer is no exception. In fact, children with acute lymphoblastic leukemia (ALL) living in poverty are significantly more likely to relapse ...
Nov 10, 2022
0
2
(HealthDay)—Nilotinib is associated with scurvy, possibly because of its effects on cutaneous metabolism, according to a letter to the editor published online April 28 in the Journal of Cutaneous Pathology.
May 11, 2016
0
1
A new study will enable clinicians to identify patients with aggressive leukemia who will not respond to chemotherapy and those who are most likely to benefit from a new immunotherapy.
Jun 5, 2020
0
113
More-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic leukemia (T-ALL). St. Jude Children's Research Hospital scientists have leveraged the latest chemical technology ...
Aug 24, 2022
0
19
Contrary to previous beliefs, stem cells, from which all new blood cells are formed, remain in bone marrow in the blood cancer type acute lymphocytic leukemia. This disease, however, causes a hidden defect in the stem cells ...
Apr 5, 2023
0
8
Leukaemia promotes premature ageing in healthy bone marrow cells—according to new research from the University of East Anglia.
Jan 30, 2019
1
79
Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute in Barcelona have developed a cell therapy for a type of leukemia which currently has very few treatment ...
Jan 16, 2023
0
23
Babies with leukemia could get an array of new treatments after scientists used genetic engineering to reproduce a gene defect found in the disease.
Oct 7, 2022
0
64
